Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for QURE

Stock Name	Uniqure NV
Ticker	QURE(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	NL0010696654

Show aggregate QURE holdings

News associated with QURE

uniQure (NASDAQ:QURE) Receives “Buy” Rating from Chardan Capital: Chardan Capital reaffirmed their buy rating on shares of uniQure (NASDAQ:QURE – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. They currently have a $35.00 target price on the biotechnology company’s stock. Several other research analysts also recently commented on QURE. Wall Street Zen raised uniQure from a “sell” rating […] - 2025-09-09 03:10:46
uniQure (NASDAQ:QURE) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of uniQure (NASDAQ:QURE – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. QURE has been the subject of several other research reports. Guggenheim reiterated a “buy” rating and issued a $28.00 price objective on shares of uniQure in a research note […] - 2025-08-05 03:00:52
uniQure N.V. (NASDAQ:QURE) Receives $37.82 Average Target Price from Analysts: uniQure N.V. (NASDAQ:QURE – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have given a buy recommendation and two have assigned a strong buy recommendation to the company. […] - 2025-07-31 03:13:08
Analysts See 19% Gains Ahead For FHLC: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-14 09:54:06
uniQure (NASDAQ:QURE) Share Price Crosses Below Fifty Day Moving Average Following Insider Selling: Shares of uniQure N.V. (NASDAQ:QURE – Get Free Report) crossed below its fifty day moving average during trading on Monday after an insider sold shares in the company. The stock has a fifty day moving average of $14.29 and traded as low as $13.65. uniQure shares last traded at $13.95, with a volume of 1,978,275 […] - 2025-06-24 02:20:53
uniQure (NASDAQ:QURE) Shares Acquired by Assenagon Asset Management S.A.: Assenagon Asset Management S.A. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 355.2% during the first quarter, HoldingsChannel reports. The fund owned 334,894 shares of the biotechnology company’s stock after buying an additional 261,323 shares during the period. Assenagon Asset Management S.A.’s holdings in uniQure were worth $3,550,000 at the end of the […] - 2025-06-16 05:08:54
uniQure (NASDAQ:QURE) Receives $37.82 Average Price Target from Analysts: uniQure (NASDAQ:QURE – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the […] - 2025-06-11 04:20:59
Bank of America Corp DE Sells 182,421 Shares of uniQure (NASDAQ:QURE): Bank of America Corp DE cut its holdings in uniQure (NASDAQ:QURE – Free Report) by 72.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 69,064 shares of the biotechnology company’s stock after selling 182,421 shares during the period. Bank of America Corp DE’s holdings in uniQure were worth $1,220,000 as of its most recent […] - 2025-06-06 04:37:00
Stock Traders Buy Large Volume of uniQure Call Options (NASDAQ:QURE): uniQure (NASDAQ:QURE – Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors bought 8,961 call options on the company. This is an increase of 314% compared to the average volume of 2,162 call options. Institutional Inflows and Outflows Several hedge funds and other institutional investors have recently bought and sold […] - 2025-06-05 02:26:44
uniQure Sees Unusually High Options Volume (NASDAQ:QURE): uniQure (NASDAQ:QURE – Get Free Report) saw unusually large options trading on Wednesday. Stock traders acquired 3,615 put options on the company. This is an increase of approximately 102% compared to the average volume of 1,792 put options. Analysts Set New Price Targets QURE has been the topic of a number of research analyst reports. […] - 2025-05-23 02:01:04
uniQure (NASDAQ:QURE) Upgraded at Cantor Fitzgerald: Cantor Fitzgerald upgraded shares of uniQure (NASDAQ:QURE – Free Report) to a strong-buy rating in a research note issued to investors on Monday,Zacks.com reports. Cantor Fitzgerald also issued estimates for uniQure’s FY2025 earnings at ($2.76) EPS. Several other research analysts have also recently commented on QURE. HC Wainwright restated a “buy” rating and issued a […] - 2025-05-22 04:50:48
Ameriprise Financial Inc. Sells 333,968 Shares of uniQure (NASDAQ:QURE): Ameriprise Financial Inc. decreased its holdings in shares of uniQure (NASDAQ:QURE – Free Report) by 38.6% in the fourth quarter, Holdings Channel reports. The firm owned 531,830 shares of the biotechnology company’s stock after selling 333,968 shares during the quarter. Ameriprise Financial Inc.’s holdings in uniQure were worth $9,392,000 at the end of the most […] - 2025-05-21 04:26:50
Chardan Capital Reaffirms “Buy” Rating for uniQure (NASDAQ:QURE): uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Chardan Capital in a report released on Monday,Benzinga reports. They currently have a $38.00 price objective on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 196.64% from the stock’s previous close. QURE […] - 2025-05-14 02:56:49
uniQure (NASDAQ:QURE) Earns Buy Rating from Guggenheim: uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Guggenheim in a note issued to investors on Monday,Benzinga reports. They currently have a $28.00 price target on the biotechnology company’s stock. Guggenheim’s price objective suggests a potential upside of 118.58% from the stock’s current price. A number of […] - 2025-05-14 02:56:48
uniQure (NASDAQ:QURE) Position Lowered by Stifel Financial Corp: Stifel Financial Corp reduced its position in uniQure (NASDAQ:QURE – Free Report) by 7.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,168 shares of the biotechnology company’s stock after selling 4,828 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-09 05:28:58
uniQure (NASDAQ:QURE) Short Interest Up 19.8% in April: uniQure (NASDAQ:QURE – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 5,260,000 shares, a growth of 19.8% from the March 31st total of 4,390,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the […] - 2025-05-05 04:58:48
uniQure (NASDAQ:QURE) Earns “Buy” Rating from HC Wainwright: uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $70.00 target price on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 386.45% from […] - 2025-04-23 02:34:42
Pre-Market Most Active for Apr 17, 2025 : HTZ, TSLL, NVDA, TQQQ, SQQQ, QURE, TSM, HIMS, NVO, UNH, BABA, NIO: The NASDAQ 100 Pre-Market Indicator is up 152.15 to 18,409.79. The total Pre-Market volume is currently 187,788,799 shares traded.The following are the most active stocks for the pre-market session: Hertz Global Holdings, Inc (HTZ) is +1.35 at $7.06, with 12,622,622 shares trade - 2025-04-17 09:28:52
Alliancebernstein L.P. Increases Stock Position in uniQure (NASDAQ:QURE): Alliancebernstein L.P. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 14.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 203,919 shares of the biotechnology company’s stock after acquiring an additional 25,319 shares during the quarter. Alliancebernstein L.P.’s holdings in uniQure were worth $3,601,000 as of its most recent filing with […] - 2025-04-15 04:50:49
uniQure (NASDAQ:QURE) Coverage Initiated at Chardan Capital: Equities researchers at Chardan Capital initiated coverage on shares of uniQure (NASDAQ:QURE – Get Free Report) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 257.82% from […] - 2025-04-03 04:26:59
Analysts Set uniQure (NASDAQ:QURE) PT at $38.89: Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-03-28 04:56:46
uniQure (NASDAQ:QURE) Rating Increased to Sell at StockNews.com: uniQure (NASDAQ:QURE – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Tuesday. QURE has been the subject of a number of other research reports. Cantor Fitzgerald lifted their target price on shares of uniQure from $28.00 to $58.00 […] - 2025-03-13 04:26:52
uniQure (NASDAQ:QURE) Receives Buy Rating from HC Wainwright: uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $70.00 price target on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 478.99% from the stock’s previous close. Several other equities research […] - 2025-03-06 06:56:12
William Blair Predicts uniQure’s Q1 Earnings (NASDAQ:QURE): uniQure (NASDAQ:QURE – Free Report) – William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of uniQure in a report released on Thursday, February 27th. William Blair analyst S. Corwin now anticipates that the biotechnology company will post earnings of ($1.48) per share for the quarter, down from their prior forecast […] - 2025-03-04 04:33:08
Y Intercept Hong Kong Ltd Lowers Stake in uniQure (NASDAQ:QURE): Y Intercept Hong Kong Ltd lowered its stake in shares of uniQure (NASDAQ:QURE – Free Report) by 50.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,319 shares of the biotechnology company’s stock after selling 29,014 shares during the period. Y Intercept Hong Kong Ltd owned […] - 2025-03-03 06:28:55
uniQure (NASDAQ:QURE) Receives $40.00 Average Price Target from Analysts: Shares of uniQure (NASDAQ:QURE – Get Free Report) have received a consensus rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating on the […] - 2025-02-06 05:00:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) QURE holdings

Date	Number of QURE Shares Held	Base Market Value of QURE Shares	Local Market Value of QURE Shares	Change in QURE Shares Held	Change in QURE Base Value	Current Price per QURE Share Held	Previous Price per QURE Share Held
2025-11-11 (Tuesday)	35,480	USD 1,094,203	USD 1,094,203
2025-11-10 (Monday)	35,480	USD 927,802	USD 927,802	91	USD -55,658	USD 26.15	USD 27.79
2025-11-07 (Friday)	35,389	USD 983,460	USD 983,460	0	USD 9,909	USD 27.79	USD 27.51
2025-11-06 (Thursday)	35,389	USD 973,551	USD 973,551	91	USD 53,685	USD 27.51	USD 26.06
2025-11-05 (Wednesday)	35,298	USD 919,866	USD 919,866	0	USD -154,605	USD 26.06	USD 30.44
2025-11-04 (Tuesday)	35,298	USD 1,074,471	USD 1,074,471	91	USD -132,777	USD 30.44	USD 34.29
2025-11-03 (Monday)	35,207	USD 1,207,248	USD 1,207,248	0	USD -1,175,914	USD 34.29	USD 67.69
2025-10-31 (Friday)	35,207	USD 2,383,162	USD 2,383,162	0	USD -5,985	USD 67.69	USD 67.86
2025-10-30 (Thursday)	35,207	USD 2,389,147	USD 2,389,147	455	USD -63,997	USD 67.86	USD 70.59
2025-10-29 (Wednesday)	34,752	USD 2,453,144	USD 2,453,144	182	USD 33,244	USD 70.59	USD 70
2025-10-28 (Tuesday)	34,570	USD 2,419,900	USD 2,419,900	0	USD 71,906	USD 70	USD 67.92
2025-10-27 (Monday)	34,570	USD 2,347,994	USD 2,347,994	0	USD 238,878	USD 67.92	USD 61.01

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of QURE by Blackrock for IE00BYXG2H39

Show aggregate share trades of QURE

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 91 28.770 25.240 25.593 USD 2,329 18.00
2025-11-06 BUY 91 30.190 26.200 26.599 USD 2,421 17.90
2025-11-04 BUY 91 32.490 28.500 28.899 USD 2,630 17.79
2025-10-30 BUY 455 69.990 67.760 67.983 USD 30,932 17.18
2025-10-29 BUY 182 70.590 70.880 70.851 USD 12,895 16.90
2025-10-22 SELL -364 59.910 63.400 63.051 USD -22,951 15.64 Loss of -17,258 on sale
2025-10-20 BUY 182 63.920 64.750 64.667 USD 11,769 15.12
2025-10-17 BUY 455 58.000 60.380 60.142 USD 27,365 14.88
2025-10-15 BUY 728 62.830 62.900 62.893 USD 45,786 14.62
2025-10-03 BUY 623 54.920 57.570 57.305 USD 35,701 14.14
2025-10-02 BUY 89 54.500 56.990 56.741 USD 5,050 13.92
2025-09-30 BUY 178 58.370 60.700 60.467 USD 10,763 13.43
2025-09-26 BUY 178 54.310 55.110 55.030 USD 9,795 12.93
2025-09-25 BUY 178 52.650 54.980 54.747 USD 9,745 12.70
2025-09-24 SELL -2,069 47.500 51.210 50.839 USD -105,186 12.50 Loss of -79,323 on sale
2025-09-18 BUY 97 14.740 14.870 14.857 USD 1,441 12.49
2025-09-17 BUY 291 14.160 15.140 15.042 USD 4,377 12.48
2025-08-20 SELL -380 15.480 15.525 15.520 USD -5,898 12.41 Loss of -1,184 on sale
2025-07-30 BUY 380 14.460 16.285 16.102 USD 6,119 12.32
2025-07-17 SELL -190 15.200 15.835 15.772 USD -2,997 12.17 Loss of -684 on sale
2025-07-11 SELL -768 14.400 15.000 14.940 USD -11,474 12.11 Loss of -2,173 on sale
2025-07-07 BUY 288 14.310 14.510 14.490 USD 4,173 12.04
2025-07-02 BUY 5,280 14.280 14.750 14.703 USD 77,632 12.01
2025-06-20 BUY 1,790 14.210 15.160 15.065 USD 26,966 11.99
2025-06-11 BUY 180 16.220 17.140 17.048 USD 3,069 11.81
2025-06-10 BUY 180 16.340 17.600 17.474 USD 3,145 11.78
2025-06-04 SELL -90 14.960 15.447 15.398 USD -1,386 11.63 Loss of -339 on sale
2025-04-23 BUY 90 14.390 15.350 15.254 USD 1,373 10.87
2025-04-10 SELL -720 8.570 8.920 8.885 USD -6,397 10.85 Profit of 1,417 on sale
2025-04-08 SELL -90 8.340 9.440 9.330 USD -840 10.90 Profit of 141 on sale
2025-04-07 SELL -90 8.760 9.300 9.246 USD -832 10.93 Profit of 151 on sale
2025-04-04 SELL -455 8.960 9.490 9.437 USD -4,294 10.95 Profit of 688 on sale
2025-04-01 BUY 368 9.910 11.430 11.278 USD 4,150 10.97
2025-03-31 SELL -273 10.600 11.400 11.320 USD -3,090 10.97 Loss of -96 on sale
2025-03-21 BUY 4,144 13.700 14.530 14.447 USD 59,868 10.76
2025-03-14 SELL -1,248 14.200 14.680 14.632 USD -18,261 10.53 Loss of -5,122 on sale
2025-03-07 SELL -154 12.230 12.770 12.716 USD -1,958 10.36 Loss of -362 on sale
2025-03-04 SELL -78 11.330 11.570 11.546 USD -901 10.29 Loss of -98 on sale
2025-02-25 BUY 156 10.990 11.460 11.413 USD 1,780 10.16
2025-02-19 SELL -77 13.410 13.610 13.590 USD -1,046 9.97 Loss of -279 on sale
2025-02-13 BUY 228 13.250 13.550 13.520 USD 3,083 9.67
2025-02-12 BUY 77 13.300 13.390 13.381 USD 1,030 9.60
2025-02-11 BUY 304 13.160 13.400 13.376 USD 4,066 9.52
2024-12-30 SELL -390 17.220 17.790 17.733 USD -6,916 6.67 Loss of -4,313 on sale
2024-11-18 SELL -1,170 6.180 6.310 6.297 USD -7,367 6.53 Profit of 268 on sale
2024-11-08 SELL -78 7.790 7.890 7.880 USD -615 6.42 Loss of -114 on sale
2024-10-21 SELL -78 6.600 6.600 6.600 USD -515 0.00 Loss of -515 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	91	28.770	25.240	25.593	USD 2,329	18.00
2025-11-06	BUY	91	30.190	26.200	26.599	USD 2,421	17.90
2025-11-04	BUY	91	32.490	28.500	28.899	USD 2,630	17.79
2025-10-30	BUY	455	69.990	67.760	67.983	USD 30,932	17.18
2025-10-29	BUY	182	70.590	70.880	70.851	USD 12,895	16.90
2025-10-22	SELL	-364	59.910	63.400	63.051	USD -22,951	15.64 Loss of -17,258 on sale
2025-10-20	BUY	182	63.920	64.750	64.667	USD 11,769	15.12
2025-10-17	BUY	455	58.000	60.380	60.142	USD 27,365	14.88
2025-10-15	BUY	728	62.830	62.900	62.893	USD 45,786	14.62
2025-10-03	BUY	623	54.920	57.570	57.305	USD 35,701	14.14
2025-10-02	BUY	89	54.500	56.990	56.741	USD 5,050	13.92
2025-09-30	BUY	178	58.370	60.700	60.467	USD 10,763	13.43
2025-09-26	BUY	178	54.310	55.110	55.030	USD 9,795	12.93
2025-09-25	BUY	178	52.650	54.980	54.747	USD 9,745	12.70
2025-09-24	SELL	-2,069	47.500	51.210	50.839	USD -105,186	12.50 Loss of -79,323 on sale
2025-09-18	BUY	97	14.740	14.870	14.857	USD 1,441	12.49
2025-09-17	BUY	291	14.160	15.140	15.042	USD 4,377	12.48
2025-08-20	SELL	-380	15.480	15.525	15.520	USD -5,898	12.41 Loss of -1,184 on sale
2025-07-30	BUY	380	14.460	16.285	16.102	USD 6,119	12.32
2025-07-17	SELL	-190	15.200	15.835	15.772	USD -2,997	12.17 Loss of -684 on sale
2025-07-11	SELL	-768	14.400	15.000	14.940	USD -11,474	12.11 Loss of -2,173 on sale
2025-07-07	BUY	288	14.310	14.510	14.490	USD 4,173	12.04
2025-07-02	BUY	5,280	14.280	14.750	14.703	USD 77,632	12.01
2025-06-20	BUY	1,790	14.210	15.160	15.065	USD 26,966	11.99
2025-06-11	BUY	180	16.220	17.140	17.048	USD 3,069	11.81
2025-06-10	BUY	180	16.340	17.600	17.474	USD 3,145	11.78
2025-06-04	SELL	-90	14.960	15.447	15.398	USD -1,386	11.63 Loss of -339 on sale
2025-04-23	BUY	90	14.390	15.350	15.254	USD 1,373	10.87
2025-04-10	SELL	-720	8.570	8.920	8.885	USD -6,397	10.85 Profit of 1,417 on sale
2025-04-08	SELL	-90	8.340	9.440	9.330	USD -840	10.90 Profit of 141 on sale
2025-04-07	SELL	-90	8.760	9.300	9.246	USD -832	10.93 Profit of 151 on sale
2025-04-04	SELL	-455	8.960	9.490	9.437	USD -4,294	10.95 Profit of 688 on sale
2025-04-01	BUY	368	9.910	11.430	11.278	USD 4,150	10.97
2025-03-31	SELL	-273	10.600	11.400	11.320	USD -3,090	10.97 Loss of -96 on sale
2025-03-21	BUY	4,144	13.700	14.530	14.447	USD 59,868	10.76
2025-03-14	SELL	-1,248	14.200	14.680	14.632	USD -18,261	10.53 Loss of -5,122 on sale
2025-03-07	SELL	-154	12.230	12.770	12.716	USD -1,958	10.36 Loss of -362 on sale
2025-03-04	SELL	-78	11.330	11.570	11.546	USD -901	10.29 Loss of -98 on sale
2025-02-25	BUY	156	10.990	11.460	11.413	USD 1,780	10.16
2025-02-19	SELL	-77	13.410	13.610	13.590	USD -1,046	9.97 Loss of -279 on sale
2025-02-13	BUY	228	13.250	13.550	13.520	USD 3,083	9.67
2025-02-12	BUY	77	13.300	13.390	13.381	USD 1,030	9.60
2025-02-11	BUY	304	13.160	13.400	13.376	USD 4,066	9.52
2024-12-30	SELL	-390	17.220	17.790	17.733	USD -6,916	6.67 Loss of -4,313 on sale
2024-11-18	SELL	-1,170	6.180	6.310	6.297	USD -7,367	6.53 Profit of 268 on sale
2024-11-08	SELL	-78	7.790	7.890	7.880	USD -615	6.42 Loss of -114 on sale
2024-10-21	SELL	-78	6.600	6.600	6.600	USD -515	0.00 Loss of -515 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of QURE

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	318,371	0	552,526	57.6%
2025-09-18	239,746	0	508,307	47.2%
2025-09-17	250,676	3,211	512,403	48.9%
2025-09-16	226,200	7,479	488,784	46.3%
2025-09-15	1,006,907	8,896	1,663,718	60.5%
2025-09-12	76,438	320	271,891	28.1%
2025-09-11	92,260	0	323,503	28.5%
2025-09-10	80,557	0	321,207	25.1%
2025-09-09	169,078	0	331,643	51.0%
2025-09-08	196,897	830	532,970	36.9%
2025-09-05	545,994	0	1,249,601	43.7%
2025-09-04	128,768	0	375,712	34.3%
2025-09-03	194,785	8	647,015	30.1%
2025-09-02	134,964	0	585,954	23.0%
2025-08-29	150,710	1,006	258,556	58.3%
2025-08-28	163,067	0	520,913	31.3%
2025-08-27	83,358	0	179,190	46.5%
2025-08-26	70,531	1	135,861	51.9%
2025-08-25	67,140	0	139,253	48.2%
2025-08-22	90,341	700	528,219	17.1%
2025-08-21	86,797	0	420,383	20.6%
2025-08-20	96,859	100	165,461	58.5%
2025-08-19	122,859	291	270,537	45.4%
2025-08-18	95,382	0	227,461	41.9%
2025-08-15	184,172	1,751	446,159	41.3%
2025-08-14	158,615	1,100	612,145	25.9%
2025-08-13	95,335	5,115	216,405	44.1%
2025-08-12	153,470	19,303	335,019	45.8%
2025-08-11	421,439	6,113	632,514	66.6%
2025-08-08	104,884	1,500	171,550	61.1%
2025-08-07	128,206	0	245,880	52.1%
2025-08-06	139,996	0	301,278	46.5%
2025-08-05	204,717	144	757,591	27.0%
2025-08-04	144,853	0	301,268	48.1%
2025-08-01	129,384	0	304,756	42.5%
2025-07-31	266,949	300	513,121	52.0%
2025-07-30	531,544	40,855	1,489,796	35.7%
2025-07-29	889,600	28,559	1,625,471	54.7%
2025-07-28	178,706	561	252,787	70.7%
2025-07-25	164,372	0	238,949	68.8%
2025-07-24	202,668	0	363,836	55.7%
2025-07-23	358,715	0	866,421	41.4%
2025-07-22	272,275	114	472,026	57.7%
2025-07-21	142,949	0	304,017	47.0%
2025-07-18	338,606	1,158	547,749	61.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE